On February 7, 2025, the U.S. National Institutes of Health announced a decision to cap indirect cost reimbursement-which supports the critical infrastructure and staff that make biomedical research possible-at 15%.
Clinicians Star in Off-Broadway Musical About Antimicrobial Resistance
It’s not every day that working scientists and healthcare professionals sing alongside seasoned actors in a show, let alone in a musical about a pressing